​

Danaher (DHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DHR Stock Forecast

Danaher (DHR) stock forecast, based on 39 Wall Street analysts, predicts a 12-month average price target of $255.17, with a high of $285.00 and a low of $231.00. This represents a 28.27% increase from the last price of $198.93.

$195 $213 $231 $249 $267 $285 High: $285 Avg: $255.17 Low: $231 Last Closed Price: $198.93

DHR Stock Rating

Danaher stock's rating consensus is Buy, based on 39 Wall Street analysts. The breakdown includes 1 Strong Buy (2.56%), 29 Buy (74.36%), 8 Hold (20.51%), 1 Sell (2.56%), and 0 Strong Sell (0.00%).

Buy
Total 39 1 8 29 1 Strong Sell Sell Hold Buy Strong Buy

DHR Price Target Upside V Benchmarks

TypeNameUpside
StockDanaher28.27%
SectorHealthcare Stocks 30.37%
IndustryDiagnostics & Research Stocks33.90%

Price Target Trends

1M3M12M
# Anlaysts3411
Avg Price Target$237.00$242.75$268.91
Last Closing Price$198.93$198.93$198.93
Upside/Downside19.14%22.03%35.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 254185--27
Mar, 253187--28
Feb, 255176--28
Jan, 255185--28
Dec, 245185--28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 23, 2025Dan LeonardUBS$240.00$196.3122.26%20.65%
Apr 22, 2025Matthew SykesGoldman Sachs$240.00$192.0724.95%20.65%
Apr 16, 2025Catherine Ramsey SchulteRobert W. Baird$231.00$190.6621.16%16.12%
Mar 14, 2025Stifel Nicolaus$260.00$210.7423.37%30.70%
Jan 15, 2025Matthew SykesGoldman Sachs$250.00$237.975.06%25.67%
Dec 19, 2024Subbu NambiGuggenheim$275.00$228.6620.27%38.24%
Oct 31, 2024Doug SchenkelWolfe Research$285.00$242.3217.61%43.27%
Oct 23, 2024Paul KnightKeyBanc$310.00$257.6720.31%55.83%
Oct 23, 2024Catherine SchulteRobert W. Baird$277.00$261.286.02%39.24%
Oct 23, 2024Puneet SoudaLeerink Partners$275.00$261.285.25%38.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 23, 2025UBSBuyBuyhold
Apr 07, 2025CitigroupBuyBuyhold
Feb 03, 2025Raymond JamesOutperformMarket Performdowngrade
Jan 15, 2025Goldman SachsNeutralNeutralhold
Dec 19, 2024GuggenheimBuyinitialise
Oct 23, 2024Raymond JamesOutperformOutperformhold
Oct 23, 2024Wells FargoEqual-WeightEqual-Weighthold
Oct 23, 2024Cowen & Co.BuyBuyhold
Oct 23, 2024KeyBancOverweightOverweighthold
Oct 23, 2024Leerink PartnersOutperformOutperformhold

Financial Forecast

EPS Forecast

$4 $5 $6 $7 $8 $9 $10 $11 $12 $13 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$4.97$8.77$9.80$6.44$5.33-----
Avg Forecast$5.37$8.77$9.41$7.43$7.50$7.99$8.94$10.05$11.00$11.54
High Forecast$5.48$8.95$9.80$7.48$7.54$8.38$9.92$10.38$11.47$12.04
Low Forecast$5.28$8.62$9.13$7.38$7.46$7.81$8.32$9.71$10.74$11.27
Surprise %-7.45%-4.14%-13.32%-28.93%-----

Revenue Forecast

$20B $23B $26B $29B $32B $35B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$22.28B$29.45B$31.47B$23.89B$23.88B-----
Avg Forecast$22.10B$29.25B$30.97B$27.12B$23.79B$24.41B$26.21B$27.99B$29.69B$31.82B
High Forecast$22.44B$29.71B$31.96B$27.40B$23.86B$24.94B$27.91B$28.01B$30.67B$32.87B
Low Forecast$21.80B$28.85B$30.26B$26.97B$23.73B$23.87B$25.49B$27.97B$29.15B$31.24B
Surprise %0.85%0.69%1.63%-11.90%0.37%-----

Net Income Forecast

$3B $4B $5B $7B $8B $9B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$3.65B$6.43B$7.21B$4.76B$3.90B-----
Avg Forecast$3.99B$6.52B$3.80B$4.20B$5.53B$5.97B$6.72B$7.41B$8.11B$8.51B
High Forecast$4.07B$6.65B$4.56B$5.04B$5.56B$6.18B$7.31B$7.65B$8.46B$8.87B
Low Forecast$3.92B$6.40B$3.04B$3.36B$5.50B$5.76B$6.13B$7.16B$7.92B$8.30B
Surprise %-8.67%-1.31%89.61%13.43%-29.53%-----

DHR Forecast FAQ

Is Danaher stock a buy?

Danaher stock has a consensus rating of Buy, based on 39 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 29 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Danaher is a favorable investment for most analysts.

What is Danaher's price target?

Danaher's price target, set by 39 Wall Street analysts, averages $255.17 over the next 12 months. The price target range spans from $231 at the low end to $285 at the high end, suggesting a potential 28.27% change from the previous closing price of $198.93.

How does Danaher stock forecast compare to its benchmarks?

Danaher's stock forecast shows a 28.27% upside, underperforming the average forecast for the healthcare stocks sector (30.37%) and underperforming the diagnostics & research stocks industry (33.90%).

What is the breakdown of analyst ratings for Danaher over the past three months?

  • April 2025: 14.81% Strong Buy, 66.67% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 10.71% Strong Buy, 64.29% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 17.86% Strong Buy, 60.71% Buy, 21.43% Hold, 0% Sell, 0% Strong Sell.

What is Danaher’s EPS forecast?

Danaher's average annual EPS forecast for its fiscal year ending in December 2025 is $7.99, marking a 49.91% increase from the reported $5.33 in 2024. Estimates for the following years are $8.94 in 2026, $10.05 in 2027, $11 in 2028, and $11.54 in 2029.

What is Danaher’s revenue forecast?

Danaher's average annual revenue forecast for its fiscal year ending in December 2025 is $24.41B, reflecting a 2.23% increase from the reported $23.88B in 2024. The forecast for 2026 is $26.21B, followed by $27.99B for 2027, $29.69B for 2028, and $31.82B for 2029.

What is Danaher’s net income forecast?

Danaher's net income forecast for the fiscal year ending in December 2025 stands at $5.97B, representing an 53.11% increase from the reported $3.9B in 2024. Projections indicate $6.72B in 2026, $7.41B in 2027, $8.11B in 2028, and $8.51B in 2029.